Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation
Authors:
- Christophe BlanquartCBChristophe Blanquart
- Olivier BarbierOBOlivier Barbier
- Bart StaelsBSBart Staels
- Corine GlineurCGCorine Glineur
- 1 June 2003
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 85 (2-5) , 267-273
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARαNature, 2002
- Nuclear Hormone Receptors and Gene ExpressionPhysiological Reviews, 2001
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transportProceedings of the National Academy of Sciences, 2001
- Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implicationsTrends in Pharmacological Sciences, 2000
- Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear ReceptorsMolecular Cell, 2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosisCurrent Opinion in Lipidology, 1999
- Structure and specificity of nuclear receptor–coactivator interactionsGenes & Development, 1998
- Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptorsNature, 1992